These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 10484767)

  • 21. Long segment and short segment familial Hirschsprung's disease: variable clinical expression at the RET locus.
    Edery P; Pelet A; Mulligan LM; Abel L; Attié T; Dow E; Bonneau D; David A; Flintoff W; Jan D
    J Med Genet; 1994 Aug; 31(8):602-6. PubMed ID: 7815416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mutation at tyrosine 1062 in MEN2A-Ret and MEN2B-Ret impairs their transforming activity and association with shc adaptor proteins.
    Asai N; Murakami H; Iwashita T; Takahashi M
    J Biol Chem; 1996 Jul; 271(30):17644-9. PubMed ID: 8663426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular heterogeneity of RET loss of function in Hirschsprung's disease.
    Carlomagno F; De Vita G; Berlingieri MT; de Franciscis V; Melillo RM; Colantuoni V; Kraus MH; Di Fiore PP; Fusco A; Santoro M
    EMBO J; 1996 Jun; 15(11):2717-25. PubMed ID: 8654369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RET and GDNF gene scanning in Hirschsprung patients using two dual denaturing gel systems.
    Hofstra RM; Wu Y; Stulp RP; Elfferich P; Osinga J; Maas SM; Siderius L; Brooks AS; vd Ende JJ; Heydendael VM; Severijnen RS; Bax KM; Meijers C; Buys CH
    Hum Mutat; 2000; 15(5):418-29. PubMed ID: 10790203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RET alternate splicing influences the interaction of activated RET with the SH2 and PTB domains of Shc, and the SH2 domain of Grb2.
    Lorenzo MJ; Gish GD; Houghton C; Stonehouse TJ; Pawson T; Ponder BA; Smith DP
    Oncogene; 1997 Feb; 14(7):763-71. PubMed ID: 9047383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Glu632-Leu633 deletion in cysteine rich domain of Ret induces constitutive dimerization and alters the processing of the receptor protein.
    Bongarzone I; Vigano E; Alberti L; Mondellini P; Uggeri M; Pasini B; Borrello MG; Pierotti MA
    Oncogene; 1999 Aug; 18(34):4833-8. PubMed ID: 10490816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The neuron-specific Rai (ShcC) adaptor protein inhibits apoptosis by coupling Ret to the phosphatidylinositol 3-kinase/Akt signaling pathway.
    Pelicci G; Troglio F; Bodini A; Melillo RM; Pettirossi V; Coda L; De Giuseppe A; Santoro M; Pelicci PG
    Mol Cell Biol; 2002 Oct; 22(20):7351-63. PubMed ID: 12242309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cys611Ser mutation in RET proto-oncogene in a kindred with medullary thyroid carcinoma and Hirschsprung's disease.
    Nishikawa M; Murakumo Y; Imai T; Kawai K; Nagaya M; Funahashi H; Nakao A; Takahashi M
    Eur J Hum Genet; 2003 May; 11(5):364-8. PubMed ID: 12734540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [From monogenic to polygenic: model of Hirschsprung disease].
    Salomon R; Amiel J; Attié T; Pelet A; Munnich A; Lyonnet S
    Pathol Biol (Paris); 1998 Nov; 46(9):705-7. PubMed ID: 9885824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations of the RET proto-oncogene in Hirschsprung's disease.
    Edery P; Lyonnet S; Mulligan LM; Pelet A; Dow E; Abel L; Holder S; Nihoul-Fékété C; Ponder BA; Munnich A
    Nature; 1994 Jan; 367(6461):378-80. PubMed ID: 8114939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological properties of Ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype.
    Ito S; Iwashita T; Asai N; Murakami H; Iwata Y; Sobue G; Takahashi M
    Cancer Res; 1997 Jul; 57(14):2870-2. PubMed ID: 9230192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue-specific carcinogenesis in transgenic mice expressing the RET proto-oncogene with a multiple endocrine neoplasia type 2A mutation.
    Kawai K; Iwashita T; Murakami H; Hiraiwa N; Yoshiki A; Kusakabe M; Ono K; Iida K; Nakayama A; Takahashi M
    Cancer Res; 2000 Sep; 60(18):5254-60. PubMed ID: 11016655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The sensitivity of activated Cys Ret mutants to glial cell line-derived neurotrophic factor is mandatory to rescue neuroectodermic cells from apoptosis.
    Mograbi B; Bocciardi R; Bourget I; Juhel T; Farahi-Far D; Romeo G; Ceccherini I; Rossi B
    Mol Cell Biol; 2001 Oct; 21(20):6719-30. PubMed ID: 11564857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of development of multiple endocrine neoplasia type 2 and Hirschsprung's disease by ret mutations.
    Takahashi M; Asai N; Iwashita T; Murakami H; Ito S
    Recent Results Cancer Res; 1998; 154():229-36. PubMed ID: 10027003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signalling of the Ret receptor tyrosine kinase through the c-Jun NH2-terminal protein kinases (JNKS): evidence for a divergence of the ERKs and JNKs pathways induced by Ret.
    Chiariello M; Visconti R; Carlomagno F; Melillo RM; Bucci C; de Franciscis V; Fox GM; Jing S; Coso OA; Gutkind JS; Fusco A; Santoro M
    Oncogene; 1998 May; 16(19):2435-45. PubMed ID: 9627110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of SNT/FRS2 docking site on RET receptor tyrosine kinase and its role for signal transduction.
    Kurokawa K; Iwashita T; Murakami H; Hayashi H; Kawai K; Takahashi M
    Oncogene; 2001 Apr; 20(16):1929-38. PubMed ID: 11360177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation of the RET ligand, neurturin, supports multigenic inheritance in Hirschsprung disease.
    Doray B; Salomon R; Amiel J; Pelet A; Touraine R; Billaud M; Attié T; Bachy B; Munnich A; Lyonnet S
    Hum Mol Genet; 1998 Sep; 7(9):1449-52. PubMed ID: 9700200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human GFRA1: cloning, mapping, genomic structure, and evaluation as a candidate gene for Hirschsprung disease susceptibility.
    Angrist M; Jing S; Bolk S; Bentley K; Nallasamy S; Halushka M; Fox GM; Chakravarti A
    Genomics; 1998 Mar; 48(3):354-62. PubMed ID: 9545641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Congenital central hypoventilation syndrome: a novel mutation of the RET gene in an isolated case.
    Kanai M; Numakura C; Sasaki A; Shirahata E; Akaba K; Hashimoto M; Hasegawa H; Shirasawa S; Hayasaka K
    Tohoku J Exp Med; 2002 Apr; 196(4):241-6. PubMed ID: 12086152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease.
    Romeo G; Ronchetto P; Luo Y; Barone V; Seri M; Ceccherini I; Pasini B; Bocciardi R; Lerone M; Kääriäinen H
    Nature; 1994 Jan; 367(6461):377-8. PubMed ID: 8114938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.